Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2-11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population studyResearch in context

• Päätekijät: María Eugenia Toledo-Romaní (Tekijä), Carmen Valenzuela-Silva (Tekijä), Minerva Montero-Díaz (Tekijä), Luisa Iñiguez-Rojas (Tekijä), Meiby Rodríguez-González (Tekijä), Mery Martínez-Cabrera (Tekijä), Rinaldo Puga-Gómez (Tekijä), Angel German-Almeida (Tekijä), Sonsire Fernández-Castillo (Tekijä), Yanet Climent-Ruiz (Tekijä), Darielys Santana-Mederos (Tekijä), Lissette López-González (Tekijä), Ileana Morales-Suárez (Tekijä), Delaram Doroud (Tekijä), Yury Valdés-Balbín (Tekijä), Dagmar García-Rivera (Tekijä), Patrick Van der Stuyft (Tekijä), Vicente Vérez-Bencomo (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2024-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Summary: Background: Increased pediatric COVID-19 occurrence due to the SARS-CoV-2 Omicron variant has raised concerns about the effectiveness of existing vaccines. The protection provided by the SOBERANA-02-Plus vaccination scheme against this variant has not yet been studied. We aimed to evaluate...